STAAR SURGICAL COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.96 USD | +0.15% |
|
+1.23% | +50.46% |
| 04-11 | Mizuho Adjusts Price Target on STAAR Surgical to $53 From $45, Maintains Buy Rating | MT |
| 04-08 | Canaccord Genuity Raises Price Target on STAAR Surgical to $46 From $32, Maintains Hold Rating | MT |
Chart calendar STAAR Surgical Company
62a56d80809e59eadf.8bk62BDCv7UQh0CbB86zPc7IjPONnbs4s-598iUgmHU.ttpSmXGq_eRf5BrYPqXHW4as1KbE8_Nhgr4Elk1pzACZy1mwXrPZhnjeeA~aa022f92910885a625d74ff9f9bba462
Upcoming events on STAAR Surgical Company
Past events on STAAR Surgical Company
| 04/04/2024 | American Society of Cataract and Refractive Surgery Meeting |
| 19/03/2024 | Investor Meeting - Day 3 |
| 18/03/2024 | Investor Meeting - Day 2 |
| 17/03/2024 | Investor Meeting - Day 1 |
| 12/03/2024 | Sidoti Small Cap Conference |
| 11/03/2024 | Oppenheimer Healthcare MedTech & Services Conference |
| 26/02/2024 21:15 | Q4 2023 Earnings Call |
| 26/02/2024 21:01 | Q4 2023 Earnings Release |
| 16/11/2023 14:00 | Stephens Investment Conference |
| 01/11/2023 20:30 | Q3 2023 Earnings Call |
| 01/11/2023 20:01 | Q3 2023 Earnings Release |
| 14/09/2023 13:30 | Investor Day |
| 05/09/2023 | Goldman Sachs European MedTech & Healthcare Services Conference |
| 29/08/2023 | William Blair West Coast Field Trip Conference |
| 29/08/2023 | William Blair West Coast Field Trip |
| 21/08/2023 | Piper Sandler West Coast Field Trip |
| 14/08/2023 | Needham Virtual MedTech & Diagnostics Conference |
| 09/08/2023 15:00 | Canaccord Genuity Growth Conference |
| 02/08/2023 21:30 | Q2 2023 Earnings Call |
| 02/08/2023 21:01 | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 150 150 -0.01% | 163 162 0.93% | 230 231 -0.12% | 284 285 -0.15% | 322 322 0.14% | 339 |
|
EBITDA Million USD | Released Forecast Spread | 15,6 15,7 -0.95% | 0,00 0,00 - | 51,6 44,5 15.85% | 68,7 69,6 -1.25% | 56,7 51,6 10.01% | 36,6 |
|
EBIT Million USD | Released Forecast Spread | 11,9 11,2 5.7% | 6,77 4,79 41.3% | 33,3 33,0 0.98% | 43,8 45,1 -2.89% | 28,1 19,4 44.52% | 2,45 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 13,0 12,1 7.84% | 8,27 5,69 45.3% | 31,3 31,8 -1.55% | 45,8 42,2 8.52% | 33,7 22,5 49.46% | 3,53 |
|
Net income Million USD | Released Forecast Spread | 14,0 9,74 44.23% | 5,91 4,48 32.02% | 24,5 24,6 -0.49% | 39,0 34,8 11.99% | 21,3 15,0 42.61% | 0,87 |
|
EPS USD | Released Forecast Spread | 0,30 0,21 45.16% | 0,12 0,10 25% | 0,50 0,50 0.67% | 0,79 0,70 12.22% | 0,43 0,30 42.28% | 0,02 |
| Announcement Date | 26/02/20 | 24/02/21 | 23/02/22 | 21/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 59,0 59,2 -0.35% | 63,2 60,5 4.41% | 81,1 80,1 1.23% | 76,0 74,9 1.46% | 64,0 64,5 -0.65% | 73,5 66,2 11.04% | 92,3 92,5 -0.24% | 80,3 80,4 -0.08% | 76,3 75,8 0.64% | 74,7 | 95,3 | 86,9 | 81,9 | 83,4 |
|
EBITDA Million USD | Released Forecast Spread | 11,9 10,3 15.77% | 13,1 9,43 39.07% | 23,8 13,3 79.03% | 20,5 11,1 85.25% | 7,35 7,78 -5.53% | 9,99 5,23 91.1% | 18,5 18,1 2.04% | 16,5 10,9 51.23% | 12,0 8,23 45.18% | 0,54 | 16,8 | 11,5 | 7,73 | 5,80 |
|
EBIT Million USD | Released Forecast Spread | 7,38 7,01 5.3% | 12,1 5,23 131.67% | 17,0 10,3 65.32% | 13,7 8,56 60.13% | 0,96 2,21 -56.41% | 2,80 -1,12 351.05% | 8,60 10,9 -20.89% | 6,30 2,61 141.27% | 10,4 2,33 347.12% | -7,90 | 8,11 | 2,87 | -0,51 | -0,13 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6,97 7,30 -4.52% | 11,5 5,57 106.86% | 15,5 10,4 49.39% | 12,6 8,75 43.71% | 6,23 2,66 134.01% | 4,72 -0,23 2114.34% | 8,49 12,1 -29.87% | 6,75 3,26 107.05% | 13,7 2,48 454.74% | -7,47 | 8,52 | 2,84 | -0,37 | 0,78 |
|
Net income Million USD | Released Forecast Spread | 4,92 4,92 0% | 9,60 3,89 146.85% | 13,0 7,78 67.66% | 10,3 6,58 55.95% | 6,10 1,93 216.3% | 2,71 -0,41 757.48% | 6,06 8,72 -30.48% | 4,82 1,86 158.38% | 7,76 1,34 479.91% | -5,50 | 5,31 | 1,60 | -0,53 | 0,15 |
|
EPS USD | Released Forecast Spread | 0,10 0,10 0% | 0,19 0,08 137.5% | 0,26 0,16 66.4% | 0,21 0,13 58.83% | 0,12 0,04 207.69% | 0,05 -0,01 886.16% | 0,12 0,18 -31.96% | 0,10 0,04 170.27% | 0,16 0,03 475.95% | -0,11 | 0,11 | 0,03 | -0,01 | 0,00 |
| Announcement Date | 23/02/22 | 04/05/22 | 10/08/22 | 02/11/22 | 21/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 26/02/24 | - | - | - | - | - |
More events
Past sector events for STAAR Surgical Company
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- STAA Stock
- Calendar STAAR Surgical Company
